Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 1 of 3: Cell count and normalized growth rate inhibition values. - Dataset (ID:20256)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|
| SK-BR-3 | Nilotinib | 3.1623 | uM | 4 | 5000.00 | 3240.08 | 5285.00 | 5536.25 | 0.9546 | 0.8834 |
| SK-BR-3 | Etoposide | 0.0033113 | uM | 4 | 5000.00 | 3240.08 | 5592.00 | 5536.25 | 1.0101 | 1.0261 |
| SK-BR-3 | Etoposide | 0.031623 | uM | 4 | 5000.00 | 3240.08 | 5551.00 | 5536.25 | 1.0027 | 1.0069 |
| SK-BR-3 | PLX-4720 | 0.031623 | uM | 4 | 5000.00 | 3240.08 | 5856.00 | 5536.25 | 1.0578 | 1.1507 |
| SK-BR-3 | Nilotinib | 0.31623 | uM | 4 | 5000.00 | 3240.08 | 5598.00 | 5536.25 | 1.0112 | 1.0289 |
| SK-BR-3 | NVP-TAE684 | 0.0033113 | uM | 4 | 5000.00 | 3240.08 | 5711.00 | 5536.25 | 1.0316 | 1.0821 |
| SK-BR-3 | PLX-4720 | 0.1 | uM | 4 | 5000.00 | 3240.08 | 5760.00 | 5536.25 | 1.0404 | 1.1052 |
| SK-BR-3 | NVP-TAE684 | 0.1 | uM | 4 | 5000.00 | 3240.08 | 5671.00 | 5536.25 | 1.0243 | 1.0632 |
| SK-BR-3 | NVP-TAE684 | 0.01 | uM | 4 | 5000.00 | 3240.08 | 5762.00 | 5536.25 | 1.0408 | 1.1061 |
| SK-BR-3 | 0 | uM | 4 | 5000.00 | 3240.08 | 5793.00 | 5536.25 | 1.0464 | 1.1208 | |
| SK-BR-3 | Nilotinib | 0.01 | uM | 4 | 5000.00 | 3240.08 | 5456.00 | 5536.25 | 0.9855 | 0.9626 |
| SK-BR-3 | 0 | uM | 4 | 5000.00 | 3240.08 | 5530.00 | 5536.25 | 0.9989 | 0.9971 | |
| SK-BR-3 | NVP-TAE684 | 0.31623 | uM | 4 | 5000.00 | 3240.08 | 5557.00 | 5536.25 | 1.0037 | 1.0097 |
| SK-BR-3 | Etoposide | 0.01 | uM | 4 | 5000.00 | 3240.08 | 5549.00 | 5536.25 | 1.0023 | 1.0060 |
| SK-BR-3 | Etoposide | 1 | uM | 4 | 5000.00 | 3240.08 | 2674.00 | 5536.25 | 0.4830 | -0.2200 |
| SK-BR-3 | PLX-4720 | 10 | uM | 4 | 5000.00 | 3240.08 | 5470.00 | 5536.25 | 0.9880 | 0.9691 |
| SK-BR-3 | Etoposide | 10 | uM | 4 | 5000.00 | 3240.08 | 2245.00 | 5536.25 | 0.4055 | -0.3779 |
| SK-BR-3 | Nilotinib | 0.0033113 | uM | 4 | 5000.00 | 3240.08 | 5695.00 | 5536.25 | 1.0287 | 1.0745 |
| SK-BR-3 | PLX-4720 | 0.01 | uM | 4 | 5000.00 | 3240.08 | 5614.00 | 5536.25 | 1.0140 | 1.0364 |
| SK-BR-3 | 0 | uM | 4 | 5000.00 | 3240.08 | 5514.00 | 5536.25 | 0.9960 | 0.9896 | |
| SK-BR-3 | 0 | uM | 4 | 5000.00 | 3240.08 | 5395.00 | 5536.25 | 0.9745 | 0.9342 | |
| SK-BR-3 | 0 | uM | 4 | 5000.00 | 3240.08 | 5008.00 | 5536.25 | 0.9046 | 0.7566 | |
| SK-BR-3 | 0 | uM | 4 | 5000.00 | 3240.08 | 5501.00 | 5536.25 | 0.9936 | 0.9835 | |
| SK-BR-3 | 0 | uM | 4 | 5000.00 | 3240.08 | 5624.00 | 5536.25 | 1.0159 | 1.0411 | |
| SK-BR-3 | 0 | uM | 4 | 5000.00 | 3240.08 | 5536.00 | 5536.25 | 1.0000 | 0.9999 |